AKRO AKERO THERAPEUTICS INC

Ownership history in AlphaQuest LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which AlphaQuest LLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q1)
Avg. % of fund
0.02%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 9,186 +2,012 +28.0% 0.03% $436K
2025 Q2 REDUCED 7,174 -2,442 -25.4% 0.04% $383K
2025 Q1 ADDED 9,616 +1,444 +17.7% 0.04% $389K
2024 Q4 ADDED 8,172 +8,147 +32588.0% 0.03% $227K
2024 Q3 REDUCED 25 -12,584 -99.8% 0.00% $717
2024 Q2 ADDED 12,609 +12,552 +22021.1% 0.04% $296K
2024 Q1 REDUCED 57 -3,162 -98.2% 0.00% $1K
2023 Q4 INITIATED 3,219 0.02% $75K
% of Fund (quarterly)

Other funds also holding AKRO

As of 2025 Q4 — sorted by position size

Nebula Research & Development LLC 0.07% IFP Advisors, Inc 3Y 7Y 0.0%
← Back to AlphaQuest LLC Holdings